found that STING expression differs among ovarian cancer histotypes; low-grade serous ovarian carcinomas and serous borderline tumors have uniform high STING expression, while high-grade serous and endometrioid carcinomas have heterogeneous expression, and clear cell and mucinous carcinomas show low expression. This evidence concerns the gene STING1 and endometrioid adenocarcinoma.